{"Id":"CG57","LastModified":"2024-06-13T12:38:10.8190026Z","ProductType":"CG","Title":"Atopic eczema in  under 12s: diagnosis and management ","ShortTitle":null,"InDevReference":"CG/Wave11/28","MetaDescription":"This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity\n","Summary":"<p class=\"lead\">This guideline covers diagnosing and managing atopic eczema in children under&nbsp;12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.</p>\n<p class=\"NICEnormal\">In <strong>June 2023</strong>, we reviewed the evidence on emollient bath additives and updated our <a href=\"https://www.nice.org.uk/guidance/CG57/chapter/Recommendations#emollients\">recommendations on emollients</a>. For more details, see <a href=\"https://www.nice.org.uk/guidance/cg57/chapter/Update-information\">update information</a>.</p>\n<h2>Recommendations</h2>\n<p>This guideline includes recommendations on:</p>\n<ul>\n<li><a href=\"https://www.nice.org.uk/guidance/CG57/chapter/Recommendations#diagnosis\">diagnosis</a></li>\n<li><a href=\"https://www.nice.org.uk/guidance/cg57/chapter/Recommendations#assessing-severity-psychological-and-psychosocial-wellbeing-and-quality-of-life\">assessing severity, psychological and psychosocial wellbeing and quality of life</a></li>\n<li><a href=\"https://www.nice.org.uk/guidance/CG57/chapter/Recommendations#identifying-and-managing-trigger-factors\">identifying and managing trigger factors</a></li>\n<li><a href=\"https://www.nice.org.uk/guidance/CG57/chapter/Recommendations#treatment\">treatment</a></li>\n<li><a href=\"https://www.nice.org.uk/guidance/CG57/chapter/Recommendations#indications-for-referral\">indications for referral</a></li>\n</ul>\n<h2>Who is it for?</h2>\n<ul>\n<li>Healthcare professionals</li>\n<li>Commissioners and providers</li>\n<li>Children under 12 with suspected or diagnosed atopic eczema and their families or carers</li>\n</ul>\n<h2>Guideline development process</h2>\n<p><a href=\"https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-guidelines/how-we-develop-nice-guidelines\">How we develop NICE guidelines</a></p>\n<p>This guideline was previously called atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years.</p>","WithdrawnNotes":"","ProductStatus":"Published","VersionNumber":32,"PublishedDate":"2007-12-12T00:00:00","LastMajorModificationDate":"2023-06-07T00:00:00","MajorChangeDate":"2023-06-07T00:00:00","NextReviewDate":null,"CollectionTypesList":[],"AuthorList":["National Institute for Health and Care Excellence (NICE)"],"AdditionalAuthorList":[],"PublisherList":["National Institute for Health and Care Excellence (NICE)"],"AudienceList":[],"EstimatedSavings":"","EstimatedSavingsDescription":"","EstimatedSavingsImpact":null,"DevelopedAs":null,"RelevantTo":[],"TerminatedAppraisal":null,"AreasOfInterestList":[],"IndicatorSubTypeList":[],"IndicatorOldCode":null,"IndicatorOldUrl":null,"TaxonomySubjectList":[],"IPSV":"Health, well-being and care","ChapterHeadings":[{"Title":"Overview","Url":"/CG57"},{"Title":"Recommendations","Url":"/CG57/chapter/recommendations"},{"Title":"Recommendations for research","Url":"/CG57/chapter/recommendations-for-research"},{"Title":"Rationale and impact","Url":"/CG57/chapter/rationale-and-impact"},{"Title":"The algorithm","Url":"/CG57/chapter/the-algorithm"},{"Title":"Context","Url":"/CG57/chapter/context"},{"Title":"Finding more information and committee details","Url":"/CG57/chapter/finding-more-information-and-committee-details"},{"Title":"Update information","Url":"/CG57/chapter/update-information"}],"RelatedExternalList":[],"AccreditationList":[],"EndorsementList":[],"SupportingList":[],"RelatedProductList":[{"Title":"Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing","ShortTitle":null,"Id":"NG190","Url":"/newfeeds/product/NG190","Relationship":"ReadInConjunctionWith"},{"Title":"Atopic eczema in under 12s","ShortTitle":null,"Id":"QS44","Url":"/newfeeds/product/QS44","Relationship":"IsTheBasisOf"}],"RelatedResourceList":[{"Id":"16868","Url":"/newfeeds/resource/16868","Relationship":"Supports","Title":"Surveillance report 2016 â€“ Atopic eczema in under 12s: diagnosis and management (2007) NICE guideline CG57","ResourceType":"SurveillanceReport","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":1970144},{"Id":"32929","Url":"/newfeeds/resource/32929","Relationship":"Supports","Title":"2019 exceptional surveillance of atopic eczema in under 12s: diagnosis and management (NICE guideline CG57)","ResourceType":"SurveillanceReport","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":5143905},{"Id":"3921","Url":"/newfeeds/resource/3921","Relationship":"Supports","Title":"Atopic eczema in children up to 12 years","ResourceType":"InformationForThePublic","ResourceGroupsList":["InformationForThePublic"],"Status":"Published","Language":"English","Uid":151705},{"Id":"3923","Url":"/newfeeds/resource/3923","Relationship":"Supports","Title":"Full guideline","ResourceType":"FullGuidance","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":151707},{"Id":"45761","Url":"/newfeeds/resource/45761","Relationship":"Supports","Title":"Baseline assessment tool","ResourceType":"AuditAndServiceImprovement","ResourceGroupsList":["AuditAndServiceImprovement"],"Status":"Published","Language":"English","Uid":6961033},{"Id":"60545","Url":"/newfeeds/resource/60545","Relationship":"Supports","Title":"Evidence reviews - June 2023","ResourceType":"EvidenceReview","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":10084325},{"Id":"60609","Url":"/newfeeds/resource/60609","Relationship":"Supports","Title":"Resource impact statement","ResourceType":"ResourceImpact","ResourceGroupsList":["ResourceImpact"],"Status":"Published","Language":"English","Uid":10085481},{"Id":"9192","Url":"/newfeeds/resource/9192","Relationship":"Supports","Title":"Review decision - 2011","ResourceType":"ReviewDecision","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":421526},{"Id":"9193","Url":"/newfeeds/resource/9193","Relationship":"Supports","Title":"Review decision - 2014","ResourceType":"ReviewDecision","ResourceGroupsList":["Evidence"],"Status":"Published","Language":"English","Uid":421527}],"ContentPartsList":[{"TableOfContents":[{"Url":"/newfeeds/product/CG57/part/1/chapter/overview","Reference":"CG57","PartId":1,"ChapterSlug":"overview","Title":"Overview"},{"Url":"/newfeeds/product/CG57/part/1/chapter/recommendations","Reference":"CG57","PartId":1,"ChapterSlug":"recommendations","Title":"Recommendations"},{"Url":"/newfeeds/product/CG57/part/1/chapter/recommendations-for-research","Reference":"CG57","PartId":1,"ChapterSlug":"recommendations-for-research","Title":"Recommendations for research"},{"Url":"/newfeeds/product/CG57/part/1/chapter/rationale-and-impact","Reference":"CG57","PartId":1,"ChapterSlug":"rationale-and-impact","Title":"Rationale and impact"},{"Url":"/newfeeds/product/CG57/part/1/chapter/the-algorithm","Reference":"CG57","PartId":1,"ChapterSlug":"the-algorithm","Title":"The algorithm"},{"Url":"/newfeeds/product/CG57/part/1/chapter/context","Reference":"CG57","PartId":1,"ChapterSlug":"context","Title":"Context"},{"Url":"/newfeeds/product/CG57/part/1/chapter/finding-more-information-and-committee-details","Reference":"CG57","PartId":1,"ChapterSlug":"finding-more-information-and-committee-details","Title":"Finding more information and committee details"},{"Url":"/newfeeds/product/CG57/part/1/chapter/update-information","Reference":"CG57","PartId":1,"ChapterSlug":"update-information","Title":"Update information"}],"Pdf":{"Id":"bffc1ef3-075d-44af-adfc-93b0a102d8a4","MimeType":"application/pdf","FileName":"CG57 Guideline 20240514.pdf","Length":171865,"Hash":"1316870A73D1FD00DE33D6DACEB5B71564014317","Name":"default","Uid":975512529349,"Url":"/newfeeds/downloads/bffc1ef3-075d-44af-adfc-93b0a102d8a4"},"Url":"/newfeeds/product/CG57/part/1/html","Reference":"CG57","PartId":1,"Title":"Atopic eczema in  under 12s: diagnosis and management ","LegacyId":null,"Type":"UploadAndConvertContentPart","Uid":752710285,"MajorChangeDate":null}],"ProductGroup":"Guideline","ProductTypeName":"Clinical guideline","ProductTypeNamePlural":"Clinical guidelines"}